Table 4: Lists 13 potential probiotic bacteria, at the genus, species, and strain level (when applicable). Table 4 examines the 13 potential probiotic bacteria specifically for their applicability against the development of the disease Necrotising Enterocolitis (NEC), by analysing BCFA membrane content, both anteiso- and iso-, and whether the bacterium produces short-chain fatty acids (SCFA) [43,56-58, 86,87,137-142].
|
NEC Probiotic Assessment |
||||
|
Bacteria; genus, species, strain |
BCFA membrane content (%) |
Anteiso-BCFAs |
Iso-BCFAs |
SCFA production |
|
Bifidobacterium lactis AD011 |
1.5-2.5% |
Yes |
Yes |
Yes |
|
Bifidobacterium bifidum BGN4 |
12.4-13.0% |
Yes |
Yes |
Yes |
|
Bifidobacterium longum BB536 |
< 0.1%* |
Yes |
Yes |
Yes |
|
Bifidobacterium breve M-16V |
24.6-25.0% |
Yes |
Yes |
Yes |
|
Propionibacterium acidipropionici |
42.0-5450.0% |
Yes |
Yes |
Yes |
|
Propionibacterium freudenreichii |
40.0-52.0% |
Yes |
Yes |
Yes |
|
Propionibacterium jensenii |
38.0-57.0% |
Yes |
Yes |
Yes |
|
Bacillus coagulans SNZ1969 |
90-95% |
Yes |
Yes |
No |
|
Bacillus subtilis DE111 |
90-95% |
Yes |
Yes |
No |
|
Lactobacillus rhamnosus LGG |
N/A |
No |
No |
Yes |
|
Lactobacillus paracasei Lpc-37 |
< 0.1% |
Yes |
No |
Yes |
|
Lactobacillus plantarum Lp-115 |
0.80% |
Yes |
No |
Yes |